TickerFactsScreenerDevelopers

Matinas BioPharma Holdings, Inc. (MTNB) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2015: -$7.81M2016: -$6.12M2017: -$11.46M2018: -$10.32M2019: -$14.09M2020: -$17.37M2021: -$15.22M2022: -$19.16M2023: -$15.28M2024: -$15.88M2025: -$7.01M-$7.01M
2015Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$7.01M+55.9%
2024-$15.88M-4.0%
2023-$15.28M+20.2%
2022-$19.16M-25.8%
2021-$15.22M+12.3%
2020-$17.37M-23.2%
2019-$14.09M-36.5%
2018-$10.32M+9.9%
2017-$11.46M-87.3%
2016-$6.12M+21.7%
2015-$7.81M—